Recent Press Releases

AstraZeneca Announces Progress on Global PARTHENON Clinical Trial Program with BRILINTA (ticagrelor) in High-Risk Cardiovascular Disease Patient Populations in Advance of American College of Cardiology Scientific Session

AstraZeneca Announces Progress on Global PARTHENON Clinical Trial Program with BRILINTA (ticagrelor) in High-Risk Cardiovascular Disease Patient Populations in Advance of American College of...

U.S. FDA Approves Eliquis® (apixaban) To Reduce The Risk Of Blood Clots Following Hip Or Knee Replacement Surgery

U.S. FDA Approves Eliquis® (apixaban) To Reduce The Risk Of Blood Clots Following Hip Or Knee Replacement Surgery (PRINCETON, NJ and NEW YORK, N.Y., March 14) – Bristol-Myers Squibb Company...

Philadelphia Jury Awards $3 Million in Topamax Birth Defect Trial

Matthews & Associates says manufacturer ignored red flags about drug's dangers

PHILADELPHIA, March 14,

Amgen's Talimogene Laherparepvec Reduced Size Of Melanoma Tumors In New Phase 3 Retrospective Analysis

Data Showed Tumor Shrinkage in Both Injected and Metastasized Tumors

THOUSAND OAKS, Calif., March 14, 2014<

Technical Commentary on Most Active Equities: Chelsea Therapeutics Intl., Hewlett-Packard, JetBlue Airways, and American Realty Capital Properties

Editor Note: For more information about this release, please scroll to bottom.

LONDON, March 14, 2014

GSK and Theravance announce positive results from studies comparing ANORO™ ELLIPTA™ with SERETIDE® DISKUS®and ADVAIR® DISKUS® in patients with COPD

GSK and Theravance announce positive results from studies comparing ANORO™ ELLIPTA™ with SERETIDE® DISKUS®and ADVAIR® DISKUS® in patients with COPD GlaxoSmithKline plc...

Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe

Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe Granted European Patent Covering 2'-Methyl-2'-Fluoro Nucleosides for Treating Hepatitis C Virus...

ISAPS-LEAP Surgical Relief Teams© Respond To Syrian Refugee Crisis

The International Society of Aesthetic Plastic Surgery and the LEAP Foundation Have Deployed 4th Volunteer Team to Amman, Jordan for Week-Long Surgical Mission

Actelion provides update on Asahi litigation

Actelion provides update on Asahi litigation (Thomson Reuters ONE via COMTEX) -- Actelion Pharmaceuticals Ltd / Actelion provides update on Asahi litigation . Processed and transmitted by NASDAQ OMX...

Novartis Bexsero® meningitis B vaccine receives clinical recommendation for use in infants and adolescents in Australia

Novartis Bexsero® meningitis B vaccine receives clinical recommendation for use in infants and adolescents in Australia Australian recommendation adds to clinical recommendations in the Czech...

FDA Advisory committee unanimously recommends Roche's HPV Test as primary screening tool for detection of women at high risk for cervical cancer

FDA Advisory committee unanimously recommends Roche's HPV Test as primary screening tool for detection of women at high risk for cervical cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today...

Actavis Confirms Favorable Ruling in Generic Celebrex® Patent Suit

Actavis Confirms Favorable Ruling in Generic Celebrex® Patent Suit DUBLIN, March 12, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the United States District Court for the...

Mylan Comments on Favorable Ruling in Generic Celebrex(R) Patent Suit

Mylan Comments on Favorable Ruling in Generic Celebrex(R) Patent Suit PITTSBURGH, March 13, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today confirmed that the United States District Court for the...

FDA Advisory Committee Unanimously Recommends Roche's HPV Test as Primary Screening Tool for Detection of Women at High Risk for Cervical Cancer

PLEASANTON, Calif., March 12, 2014 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced t

Bayer aspires to further sales and earnings growth through 2016

Bayer aspires to further sales and earnings growth through 2016 HealthCare: significant increases in sales and margins, mainly thanks to recently launched pharmaceutical products / CropScience aims...

OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2013

Conference call to be held on Tuesday, March 11, 2014 at 4:30 p.m.

Ventana and Bayer Extend Collaboration

TUCSON, March 11, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc.

Bayer and Onyx Report Phase 3 Study Results of NEXAVAR® (sorafenib) as Adjuvant Treatment for Patients with Liver Cancer Who Have Undergone Surgery or Local Ablation

Bayer and Onyx Report Phase 3 Study Results of NEXAVAR® (sorafenib) as Adjuvant Treatment for Patients with Liver Cancer Who Have Undergone Surgery or Local Ablation WHIPPANY, N.J., THOUSAND...

Reckitt Benckiser Group PLC Acquisition

Reckitt Benckiser Group PLC Acquisition TIDMRB. RNS Number : 8879B Reckitt Benckiser Group PLC 10 March 2014 Slough, England - March 10, 2014- Reckitt Benckiser Group PLC ("RB") (LSE: RB)...